ARCHIVES

Virus Program Scientific Activities Report Concluded

This article is from The Cancer Letter archive.

Vol. 01 No. 34 | August 22, 1975

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

NCI Cancer Prevention Fellowship Program

April 28, 2000

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

New NCI Directory

May 19, 1989